Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marla C Dubinsky

Showing results (151-160 of 286) with videos related to

Pageof 29
Sort By:
Intestinal Research|November 14, 2025
The impact of inflammatory bowel disease on women's health: a cross sectional study in IndiaArshia Bhardwaj, Arshdeep Singh, Riya Sharma, et al.
Crohn'S & Colitis 360|January 6, 2025
Perspectives on Contraception, Pregnancy, and Reproductive Health Counseling from Young Women With Inflammatory Bowel DiseaseErica J Brenner, Mary E Grewe, Catalina Berenblum Tobi, et al.
Inflammatory Bowel Diseases|November 23, 2006
Antibodies to I2 predict clinical response to fecal diversion in Crohn's diseaseJacob Spivak, Carol J Landers, Eric A Vasiliauskas, et al.
Inflammatory Bowel Diseases|April 19, 2018
Extraintestinal Manifestations in Vedolizumab and Anti-TNF-Treated Patients With Inflammatory Bowel DiseaseMarla C Dubinsky, Raymond K Cross, William J Sandborn, et al.
Inflammatory Intestinal Diseases|June 30, 2020
<i>Clostridioides Difficile</i> Infection Is a Rare Cause of Infectious PouchitisMaia Kayal, Emily Tixier, Michael Plietz, et al.
Journal of Crohn'S & Colitis|April 22, 2021
Efficacy and Safety of Tofacitinib Re-treatment for Ulcerative Colitis After Treatment Interruption: Results from the OCTAVE Clinical TrialsJulian Panés, Séverine Vermeire, Marla C Dubinsky, et al.
Gastroenterology|November 23, 2020
Pregnancy and Neonatal Outcomes After Fetal Exposure to Biologics and Thiopurines Among Women With Inflammatory Bowel DiseaseUma Mahadevan, Millie D Long, Sunanda V Kane, et al.
Alimentary Pharmacology & Therapeutics|November 1, 2020
Machine learning identifies novel blood protein predictors of penetrating and stricturing complications in newly diagnosed paediatric Crohn's diseaseRyan C Ungaro, Liangyuan Hu, Jiayi Ji, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 16, 2020
Recycling of Precolectomy Anti-Tumor Necrosis Factor Agents in Chronic Pouch Inflammation Is Associated With Treatment FailureMaia Kayal, Thomas Lambin, Michael Plietz, et al.
Digestive Diseases (Basel, Switzerland)|January 5, 2023
Improvements in Disease Activity Partially Mediate the Effect of Tofacitinib Treatment on Generic and Disease-Specific Health-Related Quality of Life in Patients with Ulcerative Colitis: Data from the OCTAVE ProgramMarla C Dubinsky, Alessandro Armuzzi, Krisztina B Gecse, et al.
Pageof 29

Showing results (151-160 of 286) with videos related to

Sort By:
Pageof 29
Intestinal Research|November 14, 2025
The impact of inflammatory bowel disease on women's health: a cross sectional study in IndiaArshia Bhardwaj, Arshdeep Singh, Riya Sharma, et al.
Crohn'S & Colitis 360|January 6, 2025
Perspectives on Contraception, Pregnancy, and Reproductive Health Counseling from Young Women With Inflammatory Bowel DiseaseErica J Brenner, Mary E Grewe, Catalina Berenblum Tobi, et al.
Inflammatory Bowel Diseases|November 23, 2006
Antibodies to I2 predict clinical response to fecal diversion in Crohn's diseaseJacob Spivak, Carol J Landers, Eric A Vasiliauskas, et al.
Inflammatory Bowel Diseases|April 19, 2018
Extraintestinal Manifestations in Vedolizumab and Anti-TNF-Treated Patients With Inflammatory Bowel DiseaseMarla C Dubinsky, Raymond K Cross, William J Sandborn, et al.
Inflammatory Intestinal Diseases|June 30, 2020
<i>Clostridioides Difficile</i> Infection Is a Rare Cause of Infectious PouchitisMaia Kayal, Emily Tixier, Michael Plietz, et al.
Journal of Crohn'S & Colitis|April 22, 2021
Efficacy and Safety of Tofacitinib Re-treatment for Ulcerative Colitis After Treatment Interruption: Results from the OCTAVE Clinical TrialsJulian Panés, Séverine Vermeire, Marla C Dubinsky, et al.
Gastroenterology|November 23, 2020
Pregnancy and Neonatal Outcomes After Fetal Exposure to Biologics and Thiopurines Among Women With Inflammatory Bowel DiseaseUma Mahadevan, Millie D Long, Sunanda V Kane, et al.
Alimentary Pharmacology & Therapeutics|November 1, 2020
Machine learning identifies novel blood protein predictors of penetrating and stricturing complications in newly diagnosed paediatric Crohn's diseaseRyan C Ungaro, Liangyuan Hu, Jiayi Ji, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 16, 2020
Recycling of Precolectomy Anti-Tumor Necrosis Factor Agents in Chronic Pouch Inflammation Is Associated With Treatment FailureMaia Kayal, Thomas Lambin, Michael Plietz, et al.
Digestive Diseases (Basel, Switzerland)|January 5, 2023
Improvements in Disease Activity Partially Mediate the Effect of Tofacitinib Treatment on Generic and Disease-Specific Health-Related Quality of Life in Patients with Ulcerative Colitis: Data from the OCTAVE ProgramMarla C Dubinsky, Alessandro Armuzzi, Krisztina B Gecse, et al.
Pageof 29